Nakhle Saba, MD

• Diffuse Large B-cell Lymphoma
• Chronic Lymphocytic Leukemia

Nakhle Saba graduated from the Lebanese University in Beirut with an MD in 2005. He completed his residency in the Department of Internal Medicine at East Tennessee State University in Johnson City, TN and Tulane University in New Orleans, LA. In 2008, he started a research track training in Hematology and Medical Oncology at Tulane University, where he closely worked with Laura Levy, PhD on targeting the kinase PKCβ in B-cell Acute Lymphoblastic Leukemia and Diffuse Large B-cell Lymphoma. Dr. Saba joined the lab of Adrian Wiestner MD, PhD, in January 2012 at the National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH). His research at the NIH was focused on tumor biology and developing new therapeutic approaches for Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL). He is certified by the American Board of Internal Medicine for Internal Medicine, Hematology and Medical Oncology. Dr. Saba joined Tulane Faculty in August 2014 as an Assistant Professor of Medicine, and started a translational program in B-cell malignancies. He treats patients with various hematological malignancies with a focus on lymphoma and B-cell leukemia, and performs stem cell transplant. Dr. Saba’s research focuses B-cell malignancies, in particular on CLL and MCL biology, to identify novel therapeutic targets for these diseases.